HUMHUMANA INC

NYSE humana.com


$ 402.01 $ 6.57 (1.66 %)    

Wednesday, 17-Jul-2024 15:59:56 EDT
QQQ $ 482.23 $ -14.57 (-2.94 %)
DIA $ 412.29 $ 2.27 (0.55 %)
SPY $ 557.05 $ -7.92 (-1.4 %)
TLT $ 94.21 $ 0.02 (0.02 %)
GLD $ 227.29 $ -1.06 (-0.46 %)
$ 402.17
$ 392.51
$ 0.00 x 0
$ 0.00 x 0
$ 392.51 - $ 404.13
$ 297.88 - $ 526.87
1,832,524
na
48.46B
$ 0.89
$ 24.34
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-24-2024 03-31-2024 10-Q
2 02-15-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 04-26-2023 03-31-2023 10-Q
6 02-16-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 07-27-2022 06-30-2022 10-Q
9 04-27-2022 03-31-2022 10-Q
10 02-17-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 04-28-2021 03-31-2021 10-Q
14 02-18-2021 12-31-2020 10-K
15 11-03-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 04-29-2020 03-31-2020 10-Q
18 02-20-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 07-31-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 02-21-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-16-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 02-17-2017 12-31-2016 10-K
31 11-04-2016 09-30-2016 10-Q
32 08-03-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 02-18-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 07-29-2015 06-30-2015 10-Q
37 04-29-2015 03-31-2015 10-Q
38 02-18-2015 12-31-2014 10-K
39 11-07-2014 09-30-2014 10-Q
40 07-30-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 healthcare-investors-bet-on-easier-medicare-rules-under-potential-trump-administration

Investors expect Trump to ease Medicare Advantage regulations if he wins another term. This could lead to renewed merger talks ...

 elevance-health-beat-street-estimates-on-q2-profit-and-revenue-sticks-to-annual-guidance

Elevance Health surpasses Q2 profit and revenue estimates, reporting $43.2 billion in revenue and $2.3 billion in profit. Despi...

 truist-securities-maintains-hold-on-humana-raises-price-target-to-400

Truist Securities analyst David Macdonald maintains Humana (NYSE:HUM) with a Hold and raises the price target from $355 to $...

 ftc-investigation-uncovers-anti-competitive-practices-by-handful-of-pharmacy-benefit-managers-including-cvs-health-unitedhealth

The FTC's report reveals how major PBMs like UnitedHealth, CVS, and Cigna influence drug prices, impacting small pharmacies...

 walmart-explores-sale-of-closed-health-clinics-to-recoup-investments-report

Walmart is reportedly in talks with potential buyers to sell its recently closed medical clinics. In April, Walmart shut down a...

Core News & Articles

https://fortune.com/2024/07/02/exclusive-walmart-talks-to-sell-shuttered-medical-clinics/

 humana-has-a-positive-6-month-catalyst-path-says-bullish-analyst

Humana's new CEO could propel the company's turnaround. Analyst initiates coverage with Overweight rating and price tar...

 piper-sandler-initiates-coverage-on-humana-with-overweight-rating-announces-price-target-of-392

Piper Sandler analyst Jessica Tassan initiates coverage on Humana (NYSE:HUM) with a Overweight rating and announces Price Ta...

 morgan-stanley-initiates-coverage-on-humana-with-equal-weight-rating-announces-price-target-of-374

Morgan Stanley analyst Erin Wright initiates coverage on Humana (NYSE:HUM) with a Equal-Weight rating and announces Price Ta...

Core News & Articles

https://www.statnews.com/2024/06/21/medicare-coverage-wegovy-weight-loss-cancer-blood-tests-grail/

Core News & Articles

https://www.wsj.com/health/healthcare/medicare-will-recalculate-quality-ratings-of-medicare-advantage-plans-eebee409?mod=latest...

 cantor-fitzgerald-reiterates-neutral-on-humana-maintains-360-price-target

Cantor Fitzgerald analyst Sarah James reiterates Humana (NYSE:HUM) with a Neutral and maintains $360 price target.

 baird-initiates-coverage-on-humana-with-neutral-rating-announces-price-target-of-374

Baird analyst Michael Ha initiates coverage on Humana (NYSE:HUM) with a Neutral rating and announces Price Target of $374.

 why-unitedhealth-stock-is-sliding-wednesday

UnitedHealth Group Inc. (NYSE: UNH) saw its shares decline significantly following remarks made by CEO Andrew Witty at the Bern...